Brief: Esperion Announces $210 Mln Convertible Debt Financing
Dec 13 (Reuters) - Esperion Therapeutics Inc ESPR.O :
* ESPERION ANNOUNCES $210 MILLION CONVERTIBLE DEBT FINANCING
* ESPERION THERAPEUTICS -PURSUANT TO AGREEMENTS, CO TO ISSUE
$100
MILLION OF 5.75% CONVERTIBLE NOTES DUE 2030
Source text: ID:nGNX8zrY7h
Further company coverage: ESPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Esperion Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. RESEARCH ROUNDUP- Applied Materials, Axsome Therapeutics, Onsemi